Furthermore, we analyzed the relation between AGAP2-AS1 expression and clinicopathological characteristics of lung cancer patients, and it came out that the expression of AGAP2-AS1 was associated with TNM stage and LNM of lung cancer patients, and the higher AGAP2-AS1 expression corresponded with a lower survival rate. This evidence concerns the gene AGAP2 and lung carcinoma.